home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 17, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 549 active entries

HungaroTrial CRO

Fehervari u. 89-95.
1119 Budapest
Hungary

Phone: + 36 1 203 2134
Fax: + 36 1 203 3985

Description:

HungaroTrial is a regional CRO performing clinical operations in the Central & Eastern European Region.
Recently the company is capable to set up and conduct clinical trials in Hungary, Romania, Slovakia, Serbia, Croatia, Czech Republic, Belgium, Ukraine, Russia, Bulgaria, Poland and Bosnia.
HungaroTrial offers a comprehensive array of clinical research services for pharmaceutical, biotech and medical device companies.

We offer the following services for Phase I-IV clinical trials:

•Project Management

•Free-of-Charge Study Planning and Feasibility

•Site Selection and Support

•Study start-up

•Regulatory and EC Affairs Management

•Hospital and Investigator Grant Negotiation

•Project Training

•Site Monitoring and Site Management

•Processing SAEs

•IMP management

•Medical device trials


The main advantages of the company are flexibility, responsiveness, ability to keep timelines and cost effectiveness as well as the specialized medical knowledge of our internal medical team (12 MDs on board). These advantages were proven several times in previous projects. The carefully selected and well trained CRA team of HungaroTrial is able to work under demanding pressure and retaining total client project loyalty.

For more information, please, visit our website:
www.hungarotrial.com



Selected Categories:
Product Company   Service Company
Contract
- Research

Last update of this entry: September 27, 2017

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.